Signaturefd, LLC Ab Cellera Biologics Inc. Call Options Transaction History
Signaturefd, LLC
- $5.8 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABCL
# of Institutions
165Shares Held
111MCall Options Held
749KPut Options Held
552K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$38.5 Million0.04% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...